maaf email atau password anda salah

Satu Akun, Untuk Semua Akses

Forgot Password ? Click Here

atau Masuk melalui


Belum Memiliki Akun Daftar di Sini

Satu Akun, Untuk Semua Akses

Have an account? Log in here

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Satu Akun, Untuk Semua Akses

Enter your email, untuk mereset password

Konfirmasi Email

Kami telah mengirimkan link reset password melalui email ke

Ubah No. Telepon

Ubah Password

Topik Favorit

Hapus Berita

Apakah Anda yakin akan menghapus berita?

Ubah Data Diri

Jenis Kelamin

Dubious Research from California

Monday, 26 April 2021

After failing to pass the Phase 1 clinical trial, researchers continue to work on the Nusantara vaccine pioneered by Terawan Agus Putranto, but under a new arrangement. The Indonesian Military is said to be divided in its stance on the polemic over the vaccine. In the United States, this research is also said to be problematic. Tempo investigation found that some of the claims made by Aivita, the company that developed the dendritic cell method, did not match reality.

A number of DPR members receive shots of dr. Terawan Agus Putranto’s Nusantara Vaccine at the Gatot Soebroto Army Hospital, Central Jakarta, April 22. Special Photo . tempo : 1686117583100_

THE cellular phone of Coordinating Minister for Human Development and Culture Muhadjir Effendy rang on Friday, April 16. The caller was Minister/State Secretary Pratikno, conveying the news that President Joko Widodo had asked Muhadjir to quickly resolve the polemic over the Nusantara vaccine. Muhadjir promised that the matter could be taken care of in three days.

During that time, Muhadjir contacted the Indonesian Military (TNI) Army Chief of St


Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.


Get daily summary of exclusive and in-depth news in your email Inbox by joining the Newsletter

More Articles

More exclusive contents

  • June 5, 2023

  • May 29, 2023

  • May 22, 2023

  • May 15, 2023

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe